Ischemic bowel disease in 2021

World J Gastroenterol. 2021 Aug 7;27(29):4746-4762. doi: 10.3748/wjg.v27.i29.4746.

Abstract

Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most common type followed by AMI and CMI. There are various risk factors for the development of ISBODI. Abdominal pain is the common presenting symptom of each type. High clinical suspicion is essential in ordering appropriate tests. Imaging studies and colonoscopy with biopsy are the main diagnostic tests. Treatment varies from conservative measures to surgical resection and revascularization. Involvement of multidisciplinary team is essential in managing ISBODI. Although open surgery with revascularization plays an important role, recently there is an increasing interest in percutaneous endovascular treatment.

Keywords: Acute mesenteric ischemia; Chronic mesenteric ischemia; Colon ischemia; Endovascular treatment of acute and chronic mesenteric ischemia; Ischemic colitis.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Chronic Disease
  • Colitis, Ischemic*
  • Endovascular Procedures*
  • Humans
  • Ischemia / etiology
  • Ischemia / therapy
  • Mesenteric Ischemia* / diagnostic imaging
  • Mesenteric Ischemia* / epidemiology
  • Mesenteric Ischemia* / etiology
  • Mesenteric Vascular Occlusion*
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome